Management of coronary artery bypass graft operation in a patient with rheumatoid arthritis

Öz

Rheumatoid arthritis is an inflammatory condition with joint and systemic involvement. It is common in females than males. As many other systems, vascular system can be affected due to inflammatory process involved in rheumatoid arthritis which may lead to coronary artery disease. Treatment strategies become more important because of using specific medication for the disease. Our aim is to present a case with rheumatoid arthritis to whom coronary artery bypass graft operation was performed.

Anahtar Kelimeler

• Coronary artery disease
• Coronary artery bypass graft operation
• Rheumatoid arthritis

Romatoid artritli bir hastada koroner arter baypas greft operasyonunun yönetimi

Öz

Romatoid artrit, eklem ve sistemik tutulumunun olduğu inflamatuar bir durumdur. Kadınlarda erkeklere oranla daha sık görülür. Romatoid artritte, koroner arter hastalığına yol açabilecek inflamatuar süreçten dolayı diğer birçok sistem gibi damar sistemi de etkilenebilir. Hastalığa özel ilaç kullanılması nedeniyle tedavi stratejileri daha da önem kazanmaktadır. Amacımız koroner arter bypass greft operasyonu yapılan romatoid artritli bir olguyu sunmaktır.

Anahtar Kelimeler

• Koroner arter hastalığı
• Koroner arter baypas greft operasyonu
• Romatoid artirit

Destekleyen Kurum

Yok

Etik Beyan

Hastadan operasyon öncesi yazılı aydınlatılmış onam alınmış olup çalışma Helsinki Bildirgesine uygun olarak hazırlanmıştır.

Teşekkür

Konya Necmettin Erbakan Üniversitesi Kalp ve Damar Cerrahisi çalışanlarına katkılarından dolayı teşekkür ederiz.

Kaynakça

1. Almutairi, K., Nossent, J., Preen., David. (2021). The global prevalence of rheumatoid arthritis: a meta analysis based on systematic review. Rheumatol Int, 41(5), 863-877. doi:10.1007/s00296-020-04731-0.
2. Avina-Zubieta, J.A., Thomas, J., Sadatsafavi, M. (2021). Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis, 71(9),1524-1529. doi:10.1136/annrheumdis-2011-200726.
3. Bolten, W.W. (2006). Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs. Ann Rheum Dis, 65(1),7-13. doi:10.1136/ard.2005.03.6269.
4. Crowson, C.S., Liao, K.P., Davis, J.M., Solomon, D.H., Matterson, E.L., Knutson, K.L,...Gabriel, S.E. (2013). Rheumatoid arthritis and cardiovascular disease. Am Heart J, 166(4), 622-628.doi:10.1016/j.ahj.2013.07.010.
5. Fowler, C. (2018). Do nonsteroidal anti-inflammatory drugs impair tissue healing? JAAPA, 31(8), 1-5. doi:10.1097/01.JAA.0000541488.41149.95.
6. Galarraga, B., Khan, F., Kumar, P. (2008). C-Reactive protein: The underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology, 47(12), 1780-1784. doi:10.1093/rheumatology/ken386.
7. Geissler, J.C., Schwingens, S., Zacharias, M., Einsiedler, J., Kainz, S., Reisenegger, P.,…Kotzbeck, P. (2022). The impact of prolonged inflammation on wound healing. Biomedicines, 10(4), 856-867. doi:10.3390/biomedicines10040856.
8. Hansildaar, R., Vedder, D., Baniaamam, M. (2021). Cardiovascular risk in inflammtory arthritis: rheumatoid arthritis and gout. Lancet, 3(1),58-70. doi:10.1016/S2665-9913(20)30221-6.

9. Lei, Q., Yang, J., Li, L. (2023). Lipid metabolism and rheumatoid arthritis. Front Immunol, 14,1-14. doi:10.3389/fimmu.2023.1190607.
10. Malmberg, M., Palomaki, A., Sigila, J.O. (2021). Long term outcomes after coronary artery bypass surgery in patients with rheumatoid arthritis. Ann Med, 53(1), 1512-1519. doi:10.1080/07853890.2021.1969591.
11. Maradit-Kremers, H., Nicola, P.J., Crowson, C.S. (2005). Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum, 52(3),722-732. doi:10.1002/art.20878.
12. McGettigan, P., and Henry, D. (2006). Cardiovascular risk and inhibition of cyclooxygenase. JAMA, 296(13), 1633-1644. doi:10.1001/jama.296.13.jrv60011.
13. Naranjo, A., Sokka, T., Descalzo, M.A., Alen, J.C., Petersen, K.H., Luukkainen, R.K.,…Pincus, T. (2008). Cardiovascular disease in patients with rheumatoid arthritis: results from QUEST-RA study, 10(2), 1-10. doi:10.1186/ar2383.
14. Rezus, E., Macovei, L.A., Burlui, A.M. (2021). Ischemic heart disease and rheumatoid arthritis- Two conditions, the same backround. Life, 11(10),1042-1054.doi:10.3390/life11101042.
15. Semb, A.G., Ikdahl, E., Wibetoe, G. (2020). Atheroclerotic disease prevention in rheumatoid arthritis. Nat Rev Rheumatol,16(7),361-379. doi:10.1038/s41584-020-0428-y.
16. Sergeant, J.C., Hyrich, K.L., Anderson, J., Harding, K.K., Hope, H.F., Deborah, P.M,…Verstappen, S.M. (2018). Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS). Arthritis Res Ther, 20(1), 1-11. doi:10.1186/S13075-018-1645-5.
17. Tasbulak, O., Sahin, A.A., Kahraman, S. (2021). Impact of cardiac rehabilitation on ventricular repolarization indices following coronary artery bypass grafting. Turk Gogus Kalp Damar Cerrahisi Derg, 29(2), 143-149. doi:10.5606/tgkdc.dergisi.2021.20736.
18. Van Halm, V., Nurmohamed, M., Twisk, J. (2006). Disease modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: A case control study. Arthritis Res Ther, 8(5), R151-162. doi:10.1186/ar2045.
19. Zhang, M., Wang, M., Tai, Y., Tao, J., Zhou, W., Han, Y...Wang, Q. (2021). Triggers of cardiovascular diseases in rheumatoid arthritis. Curr Probl Cardiol, 47(6), 100853. doi:10.1016/j.cpcardiol.2021.100853.